Progress on the pathway to long COVID treatments
Nat Immunol
.
2025 Dec;26(12):2126-2129.
doi: 10.1038/s41590-025-02336-y.
Authors
Robert W Eisinger
1
,
Joseph J Breen
2
,
John Beigel
2
,
Elizabeth Geerling
3
,
Julie Gerberding
3
,
Jeffery K Taubenberger
2
Affiliations
1
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA. robert.eisinger@nih.gov.
2
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
3
Foundation for the National Institutes of Health, North Bethesda, MD, USA.
PMID:
41249484
DOI:
10.1038/s41590-025-02336-y
No abstract available